{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T09:43:53Z","timestamp":1779183833912,"version":"3.51.4"},"reference-count":44,"publisher":"Japan Endocrine Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2017]]},"DOI":"10.1507\/endocrj.ej16-0583","type":"journal-article","created":{"date-parts":[[2017,3,31]],"date-time":"2017-03-31T22:12:28Z","timestamp":1490998348000},"page":"589-596","source":"Crossref","is-referenced-by-count":5,"title":["Changes in bone metabolic parameters following oral calcium supplementation in an adult patient with vitamin D-dependent rickets type 2A"],"prefix":"10.1507","volume":"64","author":[{"given":"Yuka","family":"Kinoshita","sequence":"first","affiliation":[{"name":"Division of Nephrology & Endocrinology, Department of Medicine, the University of Tokyo Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuaki","family":"Ito","sequence":"additional","affiliation":[{"name":"Division of Nephrology & Endocrinology, Department of Medicine, the University of Tokyo Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Makita","sequence":"additional","affiliation":[{"name":"Division of Nephrology & Endocrinology, Department of Medicine, the University of Tokyo Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaomi","family":"Nangaku","sequence":"additional","affiliation":[{"name":"Division of Nephrology & Endocrinology, Department of Medicine, the University of Tokyo Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Fukumoto","sequence":"additional","affiliation":[{"name":"Fujii Memorial Institute of Medical Sciences, Tokushima University, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","unstructured":"1. Francis RM, Selby PL (1997) Osteomalacia. <i>Baillieres Clin Endocrinol Metab <\/i>11: 145-163."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Elidrissy AT (2016) The Return of Congenital Rickets, Are We Missing Occult Cases? <i>Calcif Tissue Int<\/i> 99: 227-236.","DOI":"10.1007\/s00223-016-0146-2"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Munns CF, Shaw N, Kiely M, Specker BL, Thacher TD, <i>et al<\/i>. (2016) Global Consensus Recommendations on Prevention and Management of Nutritional Rickets. <i>J Clin Endocrinol Metab <\/i>101: 394-415.","DOI":"10.1210\/jc.2015-2175"},{"key":"4","unstructured":"4. Malloy PJ, Feldman D (2010) Genetic disorders and defects in vitamin d action. <i>Endocrinol Metab Clin North Am <\/i>39: 333-346."},{"key":"5","unstructured":"5. Goldsweig BK, Carpenter TO (2015) Hypophosphatemic rickets: lessons from disrupted FGF23 control of phosphorus homeostasis. <i>Curr Osteoporos Rep <\/i>13: 88-97."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Hughes MR, Malloy PJ, Kieback DG, Kesterson RA, Pike JW, <i>et al<\/i>. (1988) Point mutations in the human vitamin D receptor gene associated with hypocalcemic rickets. <i>Science <\/i>242: 1702-1705.","DOI":"10.1126\/science.2849209"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Malloy PJ, Tasic V, Taha D, Tutunculer F, Ying GS, <i>et al<\/i>. (2014) Vitamin D receptor mutations in patients with hereditary 1,25-dihydroxyvitamin D-resistant rickets. <i>Mol Genet Metab <\/i>111: 33-40.","DOI":"10.1016\/j.ymgme.2013.10.014"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Haussler MR (1986) Vitamin D receptors: nature and function. <i>Annu Rev Nutr <\/i>6: 527-562.","DOI":"10.1146\/annurev.nu.06.070186.002523"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Bouillon R, Carmeliet G, Verlinden L, van Etten E, Verstuyf A, <i>et al<\/i>. (2008) Vitamin D and human health: lessons from vitamin D receptor null mice. <i>Endocr Rev <\/i>29: 726-776.","DOI":"10.1210\/er.2008-0004"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Christakos S, Dhawan P, Verstuyf A, Verlinden L, Carmeliet G (2016) Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects. <i>Physiol Rev <\/i>96: 365-408.","DOI":"10.1152\/physrev.00014.2015"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Kim MS, Fujiki R, Murayama A, Kitagawa H, Yamaoka K, <i>et al<\/i>. (2007) 1Alpha,25(OH)<sub>2<\/sub>D<sub>3<\/sub>-induced transrepression by vitamin D receptor through E-box-type elements in the human parathyroid hormone gene promoter. <i>Mol Endocrinol <\/i>21: 334-342.","DOI":"10.1210\/me.2006-0231"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Murayama A, Takeyama K, Kitanaka S, Kodera Y, Hosoya T, <i>et al<\/i>. (1998) The promoter of the human 25-hydroxyvitamin D<sub>3<\/sub> 1 alpha-hydroxylase gene confers positive and negative responsiveness to PTH, calcitonin, and 1 alpha,25(OH)<sub>2<\/sub>D<sub>3<\/sub>. <i>Biochem Biophys Res Commun <\/i>249: 11-16.","DOI":"10.1006\/bbrc.1998.9098"},{"key":"13","unstructured":"13. Malloy PJ, Feldman D (2011) The role of vitamin D receptor mutations in the development of alopecia. <i>Mol Cell Endocrinol <\/i>347: 90-96."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Marx SJ, Bliziotes MM, Nanes M (1986) Analysis of the relation between alopecia and resistance to 1,25-dihydroxyvitamin D. <i>Clin Endocrinol (Oxf) <\/i>25: 373-381.","DOI":"10.1111\/j.1365-2265.1986.tb01703.x"},{"key":"15","unstructured":"15. Li YC, Amling M, Pirro AE, Priemel M, Meuse J, <i>et al<\/i>. (1998) Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets, and osteomalacia, but not alopecia in vitamin D receptor-ablated mice. <i>Endocrinology <\/i>139: 4391-4396."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Yamazaki Y, Okazaki R, Shibata M, Hasegawa Y, Sato K,<i> et al<\/i>. (2002) Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets\/osteomalacia. <i>J Clin Endocrinol Metab <\/i>87: 4957-4960.","DOI":"10.1210\/jc.2002-021105"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Mechica JB, Leite MO, Mendonca BB, Frazzatto ES, Borelli A, <i>et al<\/i>. (1997) A novel nonsense mutation in the first zinc finger of the vitamin D receptor causing hereditary 1,25-dihydroxyvitamin D<sub>3<\/sub>-resistant rickets. <i>J Clin Endocrinol Metab <\/i>82: 3892-3894.","DOI":"10.1210\/jcem.82.11.4384"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Zhu W, Malloy PJ, Delvin E, Chabot G, Feldman D (1998) Hereditary 1,25-dihydroxyvitamin D-resistant rickets due to an opal mutation causing premature termination of the vitamin D receptor. <i>J Bone Miner Res <\/i>13: 259-264.","DOI":"10.1359\/jbmr.1998.13.2.259"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Zhou Y, Wang J, Malloy PJ, Dolezel Z, Feldman D (2009) Compound heterozygous mutations in the vitamin D receptor in a patient with hereditary 1,25-dihydroxyvitamin D-resistant rickets with alopecia. <i>J Bone Miner Res <\/i>24: 643-651.","DOI":"10.1359\/jbmr.081216"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Amling M, Priemel M, Holzmann T, Chapin K, Rueger JM, <i>et al<\/i>. (1999) Rescue of the skeletal phenotype of vitamin D receptor-ablated mice in the setting of normal mineral ion homeostasis: formal histomorphometric and biomechanical analyses. <i>Endocrinology <\/i>140: 4982-4987.","DOI":"10.1210\/endo.140.11.7110"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Hoenderop JG, Nilius B, Bindels RJ (2005) Calcium absorption across epithelia. <i>Physiol Rev <\/i>85: 373-422.","DOI":"10.1152\/physrev.00003.2004"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Tamura M, Isojima T, Kawashima M, Yoshida H, Yamamoto K, <i>et al<\/i>. (2015) Detection of Hereditary 1,25-Hydroxyvitamin D-Resistant Rickets Caused by Uniparental Disomy of Chromosome 12 Using Genome-Wide Single Nucleotide Polymorphism Array. <i>PLoS One <\/i>10: e0131157.","DOI":"10.1371\/journal.pone.0131157"},{"key":"23","unstructured":"23. Li YC, Bolt MJ, Cao LP, Sitrin MD (2001) Effects of vitamin D receptor inactivation on the expression of calbindins and calcium metabolism. <i>Am J Physiol Endocrinol Metab<\/i> 281: E558-564."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Friedman PA (2000) Mechanisms of renal calcium transport. <i>Exp Nephrol <\/i>8: 343-350.","DOI":"10.1159\/000020688"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Malloy PJ, Hochberg Z, Tiosano D, Pike JW, Hughes MR, <i>et al<\/i>. (1990) The molecular basis of hereditary 1,25-dihydroxyvitamin D<sub>3<\/sub> resistant rickets in seven related families. <i>J Clin Invest <\/i>86: 2071-2079.","DOI":"10.1172\/JCI114944"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, <i>et al<\/i>. (1999) Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. <i>Endocr Rev <\/i>20: 345-357.","DOI":"10.1210\/edrv.20.3.0367"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Takeda S, Yoshizawa T, Nagai Y, Yamato H, Fukumoto S,<i> et al<\/i>. (1999) Stimulation of osteoclast formation by 1,25-dihydroxyvitamin D requires its binding to vitamin D receptor (VDR) in osteoblastic cells: studies using VDR knockout mice. <i>Endocrinology <\/i>140: 1005-1008.","DOI":"10.1210\/endo.140.2.6673"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Sakai Y, Demay MB (2000) Evaluation of keratinocyte proliferation and differentiation in vitamin D receptor knockout mice. <i>Endocrinology <\/i>141: 2043-2049.","DOI":"10.1210\/endo.141.6.7515"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Dardenne O, Prud&rsquo;homme J, Arabian A, Glorieux FH, St-Arnaud R (2001) Targeted inactivation of the 25-hydroxyvitamin D(3)-1(alpha)-hydroxylase gene (CYP27B1) creates an animal model of pseudovitamin D-deficiency rickets. <i>Endocrinology <\/i>142: 3135-3141.","DOI":"10.1210\/endo.142.7.8281"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Panda DK, Miao D, Tremblay ML, Siois J, Farookhi R, <i>et al<\/i>. (2001) Targeted ablation of the 25-hydroxyvitamin D 1alpha -hydroxylase enzyme: evidence for skeletal, reproductive, and immune dysfunction. <i>Proc Natl Acad Sci U S A <\/i>98: 7498-7503.","DOI":"10.1073\/pnas.131029498"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Lo Celso C, Prowse DM, Watt FM (2004) Transient activation of beta-catenin signalling in adult mouse epidermis is sufficient to induce new hair follicles but continuous activation is required to maintain hair follicle tumours. <i>Development <\/i>131: 1787-1799.","DOI":"10.1242\/dev.01052"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Shimada T, Yamazaki Y, Takahashi M, hasegawa H, Urakawa I, <i>et al<\/i>. (2005) Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism. <i>Am J Physiol Renal Physiol<\/i> 289: 1088-1095.","DOI":"10.1152\/ajprenal.00474.2004"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Yu X, Sabbagh Y, Davis SI, Demay MB, White KE (2005) Genetic dissection of phosphate- and vitamin D-mediated regulation of circulating Fgf23 concentrations. <i>Bone <\/i>36: 971-977.","DOI":"10.1016\/j.bone.2005.03.002"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Kolek OI, Hines ER, Jones MD, LeSueur LK, Lipko MA, <i>et al<\/i>. (2005) 1alpha,25-Dihydroxyvitamin D<sub>3<\/sub> upregulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport. <i>Am J Physiol Gastrointest Liver Physiol<\/i> 289: G1036-1042.","DOI":"10.1152\/ajpgi.00243.2005"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Yamamoto R, Minamizaki T, Yoshiko Y, Yoshioka H, Tanne K, <i>et al<\/i>. (2010) 1alpha,25-dihydroxyvitamin D<sub>3<\/sub> acts predominately in mature osteoblasts under conditions of high extracellular phosphate to increase fibroblast growth factor 23 production in vitro. <i>J Endocrinol<\/i> 206: 279-286.","DOI":"10.1677\/JOE-10-0058"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Saito H, Maeda A, Ohtomo S, Hirata M, Kusano K, <i>et al<\/i>. (2005) Circulating FGF-23 is regulated by 1alpha,25-dihydroxyvitamin D<sub>3<\/sub> and phosphorus <i>in vivo<\/i>. <i>J Biol Chem <\/i>280: 2543-2549.","DOI":"10.1074\/jbc.M408903200"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Shimada T, Kakitani M, Yamazaki Y, Hasegawa H, Takeuchi Y, <i>et al<\/i>. (2004) Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. <i>J Clin Invest<\/i> 113: 561-568.","DOI":"10.1172\/JCI200419081"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Hesse M, Frohlich LF, Zeitz U, Lanske B, Erben RG (2007) Ablation of vitamin D signaling rescues bone, mineral, and glucose homeostasis in Fgf-23 deficient mice. <i>Matrix Biol<\/i> 26: 75-84.","DOI":"10.1016\/j.matbio.2006.10.003"},{"key":"39","unstructured":"39. Li YC, Kong J, Wei M, Chen ZF, Liu SQ, <i>et al<\/i>. (2002) 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. <i>J Clin Invest <\/i>110: 229-238."},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Zhou C, Lu F, Cao K, Xu D, Goltzman D, <i>et al<\/i>. (2008) Calcium-independent and 1,25(OH)<sub>2<\/sub>D<sub>3<\/sub>-dependent regulation of the renin-angiotensin system in 1alpha-hydroxylase knockout mice. <i>Kidney Int <\/i>74: 170-179.","DOI":"10.1038\/ki.2008.101"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Simpson RU, Hershey SH, Nibbelink KA (2007) Characterization of heart size and blood pressure in the vitamin D receptor knockout mouse. <i>J Steroid Biochem Mol Biol<\/i> 103: 521-524.","DOI":"10.1016\/j.jsbmb.2006.12.098"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Tiosano D, Schwartz Y, Braver Y, Hadash A, Gepstein V, <i>et al<\/i>. (2011) The renin-angiotensin system, blood pressure, and heart structure in patients with hereditary vitamin D-resistance rickets (HVDDR). <i>J Bone Miner Res <\/i>26: 2252-2260.","DOI":"10.1002\/jbmr.431"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Costa JL, Eijk PP, van de Wiel MA, ten Berge D, Schmitt F, <i>et al<\/i>. (2009) Anti-proliferative action of vitamin D in MCF7 is still active after siRNA-VDR knock-down. <i>BMC Genomics<\/i> 10: 499.","DOI":"10.1186\/1471-2164-10-499"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Brenza HL, Kimmel-Jehan C, Jehan F, Shinki T, Wakino S,<i> et al<\/i>. (1998) Parathyroid hormone activation of the 25-hydroxyvitamin D<sub>3<\/sub>-1alpha-hydroxylase gene promoter. <i>Proc Natl Acad Sci U S A <\/i>95: 1387-1391.","DOI":"10.1073\/pnas.95.4.1387"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/64\/6\/64_EJ16-0583\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T13:44:33Z","timestamp":1568987073000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/64\/6\/64_EJ16-0583\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej16-0583","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}